title: Depression in Parkinson's disease.
abstract: The prevalence of major and minor depression in Parkinson's disease is around 30-40% but, unfortunately, depression remains frequently underrecognized and often undertreated. However, recognition and appropriate treatment of depression in patients with Parkinson's disease is essential for improving the cross-sectional picture and longitudinal course. This review focuses on the epidemiology, pathophysiology and different treatment modalities of depression in Parkinson's disease.
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Rihmer
authors.forename: Xénia
authors.initials: X
authors.lastname: Gonda
authors.forename: Péter
authors.initials: P
authors.lastname: Döme
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D015897:Comorbidity; D046690:Deep Brain Stimulation; D003863:Depression / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D003865:Major Depressive Disorder / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D004565:Electroconvulsive Therapy; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology*; D015995:Prevalence; D012307:Risk Factors; D050781:Transcranial Magnetic Stimulation
chemical_list: D000928:Antidepressive Agents; D000978:Antiparkinson Agents